Group 1 - Guangxin Technology (920037) experienced a significant increase of 13.12% in stock price, with a trading volume turnover rate of 30.09% and a total transaction amount of 657 million yuan, indicating high market activity [2] - The stock was listed on the North Exchange's watchlist due to its turnover rate reaching 30.09%, with a net selling amount of 25.95 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction amount of 131 million yuan, with a buying amount of 52.68 million yuan and a selling amount of 78.63 million yuan, resulting in a net selling of 25.95 million yuan [2] Group 2 - The largest buying brokerage was Dongfang Caifu Securities, which purchased 9.12 million yuan, while the largest selling brokerage was Wanhua Securities, which sold 17.30 million yuan [2] - Detailed trading data shows the top five buying and selling brokerages, with significant amounts traded by various firms, indicating active participation in the stock [2] - The trading activity on July 3 reflects a mixed sentiment among investors, with notable buying and selling pressures observed [2]

Group 1 - The stock of Gongzhituo reached the daily limit, with a turnover rate of 6.06% and a transaction amount of 11.33 million yuan, showing a fluctuation of 8.70% [2] - The stock was listed on the Shenzhen Stock Exchange for delisting arrangement, with a net buying amount of 1.5896 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 8.5173 million yuan, with a buying amount of 5.0534 million yuan and a selling amount of 3.4639 million yuan, resulting in a net buying of 1.5896 million yuan [2] Group 2 - The largest buying brokerage was Guangfa Securities with a buying amount of 1.4437 million yuan, while the largest selling brokerage was Huaxi Securities with a selling amount of 1.3420 million yuan [2] - Over the past six months, the stock has appeared on the龙虎榜 18 times, with an average price increase of 0.02% the next day and an average decline of 1.15% in the following five days [2] - The stock saw a net inflow of 1.1347 million yuan in main funds today, with a significant single net inflow of 1.7529 million yuan and a large single outflow of 618,200 yuan [2]

据悉，信贸链的国际认可度不断提升，目前，信贸链已接入200余家服务机构，1.2万家货主企业，处理 贸易量超2000万笔，这一规模的生态体系为企业提供了一个广阔的合作平台。信贸链已和新加坡资讯通 信媒体发展局开发的TradeTrust实现对接融合，让电子提单和其他用于验证、溯源、货权转让的数字贸 易文件，在船东、货主、银行等参与方间高效安全流转。 7月3日，数字经济出海国际合作论坛在2025全球数字经济大会上举办，信贸链开源产业操作系统在现场 正式向社会发布，这一系统将为贸易主体提供全面的数字化转型服务，加速传统贸易的数字化进程，是 全球数字贸易发展的重要里程碑。 可信贸易协作网络（简称信贸链）由慧贸天下（北京）科技有限公司发起，是基于区块链技术构建的全 球贸易互操作协议，通过分布式可信协作网络推动传统贸易向数字贸易转型升级。此次发布的信贸链开 源产业操作系统是慧贸天下基于信贸链协议，利用区块链、AI技术打造的支持全链路贸易运营的数字 底座。利用该产业操作系统接入信贸链，贸易主体可轻松与上下游伙伴进行无缝协作，实现从营销、物 流、通关到结算等贸易全环节的数智化，从而实现从传统贸易向数字贸易的全面升级。 慧贸天下 ...

(责编：安霄雨、桑莉媛) 这场产能"加速度"背后，是坚实的技术底座。自2020年投入近亿元组建研发团队以来，高科华烨相继攻 克超微间距显示关键技术，率先实现0.47毫米MLED产品的规模化量产。方寸之间的精进突破，为终端 显示效果带来了质的飞跃。 高科华烨由传统资源型企业转型，深耕十余年构建起LED全产业链，凭借技术与集群优势跻身全国最大 LED封装及显示基地之列，并吸引深莞核心供应商落户长治，实现关键材料本地化配套。作为全国首批 产业转型升级示范区，长治将LED列为战略性新兴支柱产业，集聚近40家相关企业，产值占全省95%以 上；依托国家级检测平台，该市持续推进"延链补链强链"，剑指"全国LED产业之都"。(刘红、马立 明、桑莉媛、麻潞、武笑、卢鹏宇、董童、张超宁、马梦迪) 0:00 仲夏的长治，高科华烨集团MLED万级洁净车间里，一片书本大小的COB基板上竟整齐排列着86400颗 显示芯片，像素间距仅为发丝直径的七分之一。指尖轻触，表面丝滑细腻，毫无颗粒感——这0.47毫米 超微间距MLED显示屏，正是高科华烨自主突破的核心技术成果。 面对持续攀升的市场需求，高科华烨于去年11月果断启动封装产能大幅扩张。 ...

今日（7.3），创新药再度大涨。可T+0交易的恒生生物科技ETF（513280）收涨3.5%，近5日有3日获资金净流入，是同指数ETF中唯一 年内份额实现正增长的ETF！A股创新药板块，生物药ETF（159839）也收涨1.72%！ 截至收盘，恒生生物科技ETF（513280）标的指数成分股多数飘红：康方生物涨超14%，信达生物涨超6%，石药集团、三生制药涨超 3%，百济神州、中国生物制药涨超2%，药明生物微涨。 消息面上，康方生物7月3日早间宣布，自主研发的首个双抗ADC药物（抗体偶联药物）AK146D1（Trop2/Nectin4ADC），治疗晚期实体 瘤的Ia期临床研究完成首例受试者入组。康方生物总市值约950亿港元，距离千亿市值仅"一步之遥"。 AK146D1是康方生物首个进入临床阶段的双抗ADC药物。目前，该药已成功获得美国食品药品监督管理局（FDA）、澳大利亚药品管 理局（TGA）和国家药品监督管理局批准开展临床试验。据介绍，Trop2和Nectin4是极具潜力的肿瘤靶点。目前全球已有靶向Trop2或 Nectin4的单靶点ADC获批上市，但尚无同时靶向Trop2或Nectin4的双抗ADC药物获 ...

巴黎大区工商会会长Dominique Restino在欢迎辞中表示："在价值链重组、可持续发展挑战加剧、经济主权日益受到重视等诸多快速变革下，法中关 系正开启全新篇章。法国企业亟须顺应时代变局，而中国是诸多领域至关重要的战略要地，也是法国企业的重要市场——对法国优势产业企业而言更 是如此。" 第十一届中欧"欧洲论坛"现场。 2025年正值中欧建交50周年重要节点，中法两国作为东西方文明对话的典范，正以开放为锚点，深化战略协同，探索重塑增长的重心。本次论坛 以"不确定时代：开放重塑增长"为主题，特邀中法两国政商学界重磅嘉宾共同探讨两国如何实现优势互补、双方产业如何在不确定时代实现可持续增 长等关键议题。 新京报贝壳财经讯（记者丁爽）"在地缘政治和全球经济充满不确定性的时代，唯有'开放'才能在不确定中创造确定性。时值中欧建交50周年之际， 中国和欧洲作为全球两大力量、两大市场、两大文明，可为当前不确定性的时代注入更多的确定性。"6月30日，第十一届中欧国际工商学院"欧洲论 坛"在巴黎举办，论坛致辞环节，中欧国际工商学院院长汪泓表示。 法国前外交部长于贝尔·韦德里纳（Hubert Vedrine）则在主旨演讲中指出 ...

Core Viewpoint - Unum Group's shares have increased by approximately 60% over the past year due to strong performance in its growth businesses and reduced concerns regarding its legacy insurance policies [1] Group 1: Company Performance - Unum Group closed a significant transaction on July 1st, indicating active management and strategic positioning [1] - The company's growth businesses are performing well, contributing to the overall positive stock performance [1] Group 2: Market Sentiment - Fears surrounding Unum Group's legacy, toxic insurance policies have lessened, which has positively impacted investor sentiment [1]

Incyte Corporation (NASDAQ: INCY ) is a commercial-stage healthcare company. Recently, the company announced the appointment of Bill Meury as its new CEO. This decision could be interpreted as a pivot in the strategy of the company. Indeed, Mr. Meury has a strong trackAt ELAM1, we empower financial professionals and investors with the scientific and clinical expertise required to navigate the complexities of the healthcare sector. By bridging the gap between cutting-edge science and financial strategy, we h ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Adecoagro S.A. (AGRO) is an agro-industrial company. The Zacks Consensus Estimate for its current year earnings has been revised 12.5% downward over the last 60 days.Barings BDC, Inc. (BBDC) is an investment company. The Zacks Consensus Estimate for its current year earnings has been revised 4.6% downward over the last 60 days.Core Natural Resources, Inc. (CNR) is a metallurgical and thermal coal company. The Zacks Consensus Estimate ...

UnitedHealth Group (NYSE: UNH ) is currently one of the most difficult stocks to price and, consequently, to assign a specific rating. It is a time when a solid company with a business model that was previously known for its resilience is facingEquity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to reach out for coll ...